Sanctuary Advisors LLC Has $486,000 Stake in Sotera Health (NASDAQ:SHC)

Sanctuary Advisors LLC increased its position in shares of Sotera Health (NASDAQ:SHC) by 154.4% in the 3rd quarter, HoldingsChannel.com reports. The firm owned 29,088 shares of the company’s stock after purchasing an additional 17,652 shares during the quarter. Sanctuary Advisors LLC’s holdings in Sotera Health were worth $486,000 as of its most recent filing with the Securities and Exchange Commission.

Other institutional investors have also added to or reduced their stakes in the company. Neo Ivy Capital Management acquired a new stake in shares of Sotera Health during the third quarter worth $720,000. Geode Capital Management LLC increased its position in Sotera Health by 19.4% during the third quarter. Geode Capital Management LLC now owns 2,755,391 shares of the company’s stock worth $46,026,000 after acquiring an additional 447,186 shares during the period. Barclays PLC raised its stake in Sotera Health by 169.8% in the 3rd quarter. Barclays PLC now owns 473,597 shares of the company’s stock worth $7,909,000 after purchasing an additional 298,085 shares in the last quarter. Public Employees Retirement System of Ohio boosted its holdings in Sotera Health by 14.3% in the 3rd quarter. Public Employees Retirement System of Ohio now owns 54,706 shares of the company’s stock valued at $914,000 after purchasing an additional 6,826 shares during the period. Finally, iSAM Funds UK Ltd acquired a new position in shares of Sotera Health during the 3rd quarter worth approximately $259,000. 91.03% of the stock is currently owned by institutional investors.

Analyst Ratings Changes

A number of equities research analysts have recently weighed in on SHC shares. Citigroup boosted their price target on Sotera Health from $18.00 to $20.00 and gave the company a “buy” rating in a research note on Wednesday, November 6th. The Goldman Sachs Group began coverage on Sotera Health in a research report on Friday, December 6th. They set a “neutral” rating and a $14.00 target price for the company. Finally, Royal Bank of Canada restated an “outperform” rating and issued a $17.00 price target on shares of Sotera Health in a research report on Thursday, November 21st. Three analysts have rated the stock with a hold rating and four have given a buy rating to the company’s stock. According to data from MarketBeat, Sotera Health has a consensus rating of “Moderate Buy” and an average target price of $16.08.

Sotera Health Trading Up 1.7 %

Shares of SHC stock opened at $13.55 on Thursday. Sotera Health has a fifty-two week low of $10.71 and a fifty-two week high of $17.44. The stock’s fifty day moving average price is $14.31 and its two-hundred day moving average price is $14.26. The company has a debt-to-equity ratio of 4.91, a quick ratio of 2.61 and a current ratio of 2.88. The company has a market cap of $3.84 billion, a PE ratio of 54.20 and a beta of 1.96.

Sotera Health (NASDAQ:SHC) last announced its quarterly earnings data on Tuesday, November 5th. The company reported $0.17 earnings per share for the quarter, missing the consensus estimate of $0.18 by ($0.01). Sotera Health had a return on equity of 42.27% and a net margin of 6.31%. The business had revenue of $285.47 million for the quarter, compared to the consensus estimate of $278.64 million. During the same quarter in the prior year, the company earned $0.18 earnings per share. Sotera Health’s quarterly revenue was up 8.5% compared to the same quarter last year. Equities analysts predict that Sotera Health will post 0.61 EPS for the current fiscal year.

Sotera Health Profile

Sotera Health Company engages in the provision of sterilization, lab testing, and advisory services in the United States and internationally. The company operates through three segments: Sterigenics, Nordion, and Nelson Labs. It provides mission-critical end-to-end sterilization services, including gamma and electron beam irradiation, and ethylene oxide processing, as well as designs, installs, and maintains gamma irradiation systems.